X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://investors.merrimack.com/news-releases/news-release-details/merrimack-reports-ipsen-announcement-approval-us-fda-onivyder
https://endpts.com/fda-approves-taihos-lonsurf-with-bevacizumab-for-third-line-metastatic-colorectal-cancer/
https://www.onclive.com/view/folfox-produces-varying-toxicity-profile-vs-chemoradiation-in-rectal-cancer
https://www.prnewswire.com/news-releases/carsgens-cldn18-2-mab-ab011-achieves-ind-clearance-from-the-nmpa-for-the-first-line-combination-treatment-of-gastric-cancer-301816842.html
https://www.businesswire.com/news/home/20221222005382/en/Seagen-Announces-FDA-Accelerated-Approval-of-TUKYSA%C2%AE-tucatinib-in-Combination-with-Trastuzumab-for-People-with-Previously-Treated-RAS-Wild-Type-HER2-Positive-Metastatic-Colorectal-Cancer
https://www.esmo.org/oncology-news/elderly-patients-with-stage-iii-colon-cancer-may-derive-less-benefit-from-adjuvant-oxaliplatin-and-flouropyrimidines
https://www.prnewswire.com/news-releases/development-of-drug-resistance-in-colon-cancer-patients-contributed-to-failure-of-oxaliplatin-based-hipec-prodige-7-trial-301067723.html
https://www.clinicaltrialsarena.com/news/isofol-medical-start-agent-trial-mcrc/
https://www.biospace.com/article/lilly-s-pancreatic-drug-flunks-phase-iii-trial/?s=95
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-2-2019-1570003052.pdf
https://www.biospace.com/article/releases/amgen-and-allergan-s-mvasi-bevacizumab-awwb-and-kanjinti-trastuzumab-anns-now-available-in-the-united-states/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207562
https://www.pharmacompass.com/pdf/news/jiangsu-yew-pharmaceutical-co-ltd-fails-edqm-inspection-1537438043.pdf
https://www.biospace.com/article/fda-accepts-bristol-myers-combo-application/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205529
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207385
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204378
http://www.business-standard.com/article/companies/delhi-hc-rejects-sun-pharma-appeal-in-oxaliplatin-case-against-mylan-labs-117032400671_1.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207474
http://www.business-standard.com/article/companies/hc-dismisses-sun-pharma-s-plea-against-mylan-on-oxaliplatin-trademark-case-117021001172_1.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208523
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207325
http://www.drug-dev.com/Main/Current-News/G1-Therapeutics-Announces-Clinical-Trial-Collabora-1782.aspx
http://www.pharmatimes.com/news/nice_rejects_shires_pancreatic_cancer_drug_1177060
https://www.pharmacompass.com/pdf/news/qilu-pharm-co-ltds-generic-oxaliplatin-approved-in-us-as-chemotherapy-drug-1463220350.pdf
http://www.prnewswire.com/news-releases/chmp-issues-positive-opinion-for-lonsurfr-trifluridinetipiracil-for-refractory-metastatic-colorectal-cancer-300227482.html
http://www.prnewswire.com/news-releases/debiopharm-international-sas-partner-yakult-honsha-co-ltd-announces-elplat-approbation-in-gastric-cancer-in-japan-553128651.html
https://www.pharmacompass.com/pdf/news/aqvida-crowns-innovative-first-decade-with-robotic-filling-breakthrough-1443001323.pdf
http://www.biospectrumasia.com/biospectrum/news/221623/daiichi-sankyo-s-subsidiary-launches-generic-drugs
http://www.pharmabiz.com/NewsDetails.aspx?aid=85642&sid=2
Market Place
Share 
